Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.
Edward Morrow Atkinson III, Executive Vice President and Chief Technical Operations Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), recently sold a significant portion of his holdings in the ...
Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...
Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the momentum, experts worry.
Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...
Developers are hoping to turn a six-story office building in the heart of Boston’s Financial District into a 70-unit ...
7hon MSN
Residents are raising concerns after the MBTA announced plans to install a new commuter rail track on the Haverhill line in ...
Chocolate prices on the rise . The price of Valentine's Day chocolates may be leaving some with a bitter taste. "It's been a ...
If you are the owner of the contact information below, you can send updated contact information to [email protected] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results